MARKET INTEL |
PRIME GRANT

Project - W81XWH2210967

OVERVIEW

Original Description
EXPLOITING PROSTATE CANCER METABOLIC DEPENDENCIES TO DEVELOP NEW THERAPEUTICS AND CIRCULATING PROGNOSTIC AND PREDICTIVE BIOMARKERS
Grant Program (CFDA)
Assistance Type
Project Grant (B)
Place of Performance
AUS
Related Opportunity
W81XWH21PCRPIDA

STATUS

Period of Performance

9/30/22

Start Date

9/29/25

End Date
0% Complete

Funding Split

$1.0M

Federal Obligation

$0.0

Non-Federal Obligation

$1.0M

Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

ACTIVITY TIMELINE

SUBGRANT AWARDS

TRANSACTION HISTORY

ADDITIONAL DETAIL

Award ID FAIN
W81XWH2210967
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Last Modified: 9/21/22